Hanna John Walter JR sold $1.2M of CDNA
Hanna John Walter JR (President and CEO) sold 40,000 shares of CareDx, Inc. (CDNA) at an average of $29.24 ($29.00–$29.24, $1.17M total) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest information is the specific sale size, price range, and that it occurred under a pre-arranged 10b5-1 plan; this typically has limited fundamental impact but can influence short-term sentiment.
Market read
Traders may monitor for follow-on insider activity, but the disclosure alone does not change the company’s fundamentals.
What to watch
The article does not disclose any concurrent changes in guidance, contracts, or clinical/operational milestones—so the trading signal should be treated as sentiment-only.
Background
The article is an SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA) by its President and CEO, Hanna John Walter Jr.
Ticker impact
CareDx CEO sold about 40,000 shares in open-market transactions at ~$29.00–$29.24, per a newly filed SEC Form 4.
Likely limited, short-lived sentiment impact unless follow-on selling or other disclosures emerge.
The filing is a routine Form 4 open-market sale under a pre-arranged 10b5-1 plan; it provides timing/size but no new operating or financial information.
Market effects
Minimal; this is company-specific insider activity with no sector-wide catalyst described.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect diversification/liquidity needs rather than bearish expectations.
Key entities
- public_companyCareDx, Inc.
Issuer of the Form 4 insider transaction; CEO sold shares in open-market trades.
- insiderHanna John Walter Jr
President and CEO who executed the reported open-market sale under a 10b5-1 plan.
